MRK vs TFX
Merck & Co. vs Teleflex Incorporated — AI-powered side-by-side comparison
VS
TFX
Teleflex Incorporated
49
Watch
| Metric | MRK | TFX |
|---|
| AI Score |
70
|
49
|
| Price |
$130.34
|
$133.43
|
| P/E Ratio |
103.53×
|
-5.74×
|
| ROE |
34.7%
|
-29.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
75.4%
|
53.8%
|
| Debt / Equity |
1.29×
|
0.99×
|
| Dividend Yield |
2.6%
|
1.0%
|
| RSI (14) |
64.5
|
44.1
|
| Beta |
0.207
|
0.809
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for MRK versus TFX.
MRK leads by 21 points.
MRK scores 70/100 (Buy) versus TFX at 49/100 (Watch).
MRK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
TFX Committee View
60% agreement
5 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -14.5% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- ROE of only -31.9% -- cheap may mean cheap for a reason — Value
- Revenue declining -14.5% YoY -- this is not a growth story right now — Growth
- MACD histogram negative -- bearish momentum — Technical